The development model defines how R&D work progresses from an initial research concept through increasingly committed stages of development, validation, transfer, and launch. Its effectiveness depends not only on the activities performed within R&D but also on how product management, quality, regulatory, manufacturing, supply chain, marketing, and commercial teams participate at critical points. Many development delays that appear technical are actually caused by operating model failures at these interfaces: requirements remain unsettled, downstream functions join too late, evidence expectations are unclear, or teams disagree about who owns a milestone.
6.1 Mapping the End-to-End Flow from Research Through Development and Launch or Transfer
Development model design should begin with a clear view of how work actually moves from an idea or technical hypothesis to a commercial, operational, or customer-ready outcome. Organizations often possess detailed process manuals but lack an end-to-end view. Each function understands its own activities, yet no one can easily show where responsibility changes, where work waits, or which decisions determine whether a program can progress.
The appropriate starting and ending points depend on the business. A pharmaceutical organization may begin with discovery and end with regulatory approval, manufacturing readiness, and launch. An industrial company may move from advanced technology through product engineering, validation, industrialization, and production release. A software organization may begin with product discovery and continue through architecture, development, deployment, and ongoing release management. In some R&D settings, the principal endpoint is technology transfer rather than market launch.
The map should show both activities and transitions. Major phases might include opportunity definition, research, feasibility, concept development, detailed development, verification, validation, industrialization, transfer, launch readiness, and post-launch stabilization. The exact terminology is less important than identifying the points at which the nature of the work, accountability, or required evidence changes.
A useful end-to-end map captures five elements for every major phase:
- Purpose: what uncertainty must be reduced or outcome achieved during the phase.
- Primary owner: the role accountable for integrating the work and delivering the phase outcome.
- Key contributors: the functions whose input is materially required.
- Evidence: the technical, customer, regulatory, operational, or economic information expected before progression.
- Transition: the decision or handoff through which responsibility or investment moves to the next phase.
Current-state mapping should distinguish active work from waiting. Development cycle time often accumulates between activities rather than within them. A design may be complete but wait three weeks for a review. Test units may sit idle because a laboratory has no capacity. Manufacturing may receive information only after engineering release and then request redesign. Mapping elapsed time separately from work time helps reveal operating constraints that conventional process diagrams overlook.
The map should also identify feedback loops. Development is rarely a purely linear sequence. Testing may require design changes, regulatory consultation may alter evidence requirements, and manufacturing trials may expose engineering issues. The objective is not to eliminate iteration, which is inherent in innovation, but to distinguish productive learning loops from avoidable rework caused by weak requirements, late participation, or incomplete handoffs.
Programs frequently have parallel workstreams that must converge. Product design, software, manufacturing process development, clinical or regulatory work, sourcing, packaging, and commercialization may progress simultaneously. The development model should identify the synchronization points where these streams need compatible maturity. A program should not declare itself “on track” because engineering is progressing if tooling, regulatory evidence, or supplier qualification is several months behind.
Research-to-development transfer deserves particular attention. Research organizations frequently optimize for technical learning, while development teams require reproducibility, documented assumptions, defined performance ranges, and enough maturity to make product commitments. The transfer should therefore define what constitutes a sufficiently mature technology rather than relying on an informal judgment that research is “finished.” For uncertain technologies, a period of joint ownership may be preferable to a single abrupt transfer.
The same principle applies at the other end of development. Engineering completion is not the same as launch readiness. Manufacturing, quality, supply chain, service, regulatory, and commercial organizations may still face unresolved work. The endpoint should therefore reflect the outcome for which the development organization is accountable, such as validated design transfer, production release, first commercial shipment, or successful launch stabilization.
Acquisitions and joint ventures can create additional boundaries in the flow. Research may occur within one parent company, development within the venture, and manufacturing within another entity. In these settings, the map should explicitly show legal and organizational handoffs, access to shared capabilities, intellectual-property constraints, and reserved decisions. Informal coordination is especially risky when different entities are accountable for successive stages.
The final end-to-end map should be sufficiently simple that leaders can use it to diagnose flow, while detailed procedures remain within the responsible functions. Its primary value is to establish one shared view of how innovation moves through the organization and where cross-functional alignment is required for progression.
6.2 Designing Fit-for-Purpose Stage-Gates by Risk, Complexity, and Program Type
Stage-gates provide structured points at which an organization assesses evidence, commits additional resources, and decides whether a program should proceed. Their value comes from improving decision quality and preventing investment from continuing automatically. Their weakness appears when every program is forced through the same reviews, documentation requirements, and approval levels regardless of risk or complexity.
A stage-gate should correspond to a meaningful increase in commitment or change in risk. Typical decisions include whether to move from research into formal development, authorize detailed design, begin expensive validation, commit tooling or manufacturing capacity, submit to regulators, or release a product. A gate that does not affect investment, risk acceptance, or permission to proceed is more likely to be a status review than a true decision point.
The first design question is which dimensions should determine governance intensity. Relevant factors can include technical novelty, safety risk, regulatory classification, development investment, architecture impact, customer commitment, manufacturing complexity, supply-chain exposure, software or cybersecurity risk, and reversibility. A small modification to an established product should normally receive lighter governance than a new platform based on immature technology.
Organizations can translate these factors into several development pathways. A typical model might distinguish routine modifications, standard new products, complex or regulated developments, and exploratory technology programs. Each pathway can share common principles while differing in the number of formal gates, required evidence, approval level, and documentation burden.
The lighter pathway should not mean uncontrolled development. It means that evidence and approval are proportional to risk. A low-risk line extension might rely on delegated approval and a concise readiness checklist. A high-risk medical device or aerospace subsystem may require independent technical reviews, extensive verification evidence, formal configuration control, and multiple assurance functions. The operating model should explain why the difference exists.
Gate criteria should be expressed as questions that decision makers need answered. At an early concept gate, management may ask whether the customer need is credible, whether the technical concept is feasible enough to justify additional work, and whether the opportunity aligns with the portfolio. At a later validation gate, the questions may concern whether the design meets requirements, whether critical risks have been addressed, and whether manufacturing and regulatory plans are executable.
Evidence maturity should increase as commitment increases. Early gates should tolerate ranges, hypotheses, and explicit uncertainties. Demanding detailed certainty too early encourages teams to manufacture precise forecasts unsupported by evidence. Later gates should expect stronger substantiation because decisions may trigger irreversible capital, regulatory submissions, supplier commitments, or launch dates.
Stage-gates should also distinguish technical readiness from portfolio attractiveness. A program can satisfy technical criteria and still be stopped because another opportunity offers greater strategic value. Conversely, an attractive commercial opportunity should not be allowed to bypass mandatory safety, quality, or regulatory evidence. Where necessary, separate technical assurance from investment approval while coordinating the timing of the decisions.
Gate outcomes should include more than approve or reject. Programs may be approved with conditions, required to resolve a specific uncertainty before progression, redirected toward a narrower scope, paused until capacity becomes available, or returned for additional evidence. However, conditional approval should not become a routine method for advancing programs despite unresolved fundamentals. Conditions need accountable owners and completion dates.
The stage-gate model should accommodate iteration. A development team may discover evidence that requires it to revisit an earlier assumption without formally restarting the entire process. Change-control rules should distinguish material changes requiring renewed approval from normal iteration within delegated authority.
Joint ventures and partnerships may have additional gates driven by funding commitments or contractual rights. A development milestone might trigger a parent-company capital contribution, licensing payment, or decision to enter a new phase of jointly funded work. Such gates should be integrated with the technical development process where practical. Requiring teams to complete one internal review and then repeat substantially the same case for shareholder governance adds delay without improving evidence.
The strongest stage-gate systems are disciplined but not mechanical. They make explicit what must be known before additional commitments are made, vary rigor according to risk, and allow teams to move quickly when the evidence is sufficient.
6.3 Clarifying Handoffs with Quality, Regulatory, Manufacturing, and Supply Chain
Quality, regulatory, manufacturing, and supply-chain functions are often described as downstream stakeholders, but effective development models involve them well before formal transfer. Their requirements influence design choices, evidence plans, materials, suppliers, tolerances, process capability, documentation, and launch timing. Treating these functions as reviewers of nearly finished work creates predictable late-stage rework.
The operating model should specify when each function begins participating and what authority it exercises. Early involvement does not require permanent attendance at every development meeting. It requires planned participation at decisions where functional knowledge can materially alter the outcome.
Quality typically defines or interprets requirements concerning design controls, validation, traceability, risk management, documentation, change control, and product acceptance. Its role should distinguish independent assurance from routine project execution. Quality should not need to approve every technical choice, but it should possess clear authority where compliance or the integrity of the quality system is at stake.
Regulatory participation should begin when product claims, classification, market-entry pathways, evidence requirements, or design choices can influence approval. Late regulatory involvement can create costly redesign or additional studies. The development model should specify when regulatory strategy is required, who owns interactions with authorities, and what constitutes sufficient evidence for relevant development milestones.
Manufacturing should participate while design flexibility remains. Issues such as process capability, assembly complexity, tooling, tolerances, yield, testability, automation, maintenance, and operator requirements are difficult to address economically after design freeze. Manufacturing involvement should increase as the program approaches industrialization, but manufacturability should be considered much earlier.
Supply chain and procurement provide information about supplier capability, lead times, cost, continuity risk, logistics, material availability, localization, and component lifecycle. A technically optimal component can become a poor development choice if it is available from only one unstable supplier or requires lead times inconsistent with the launch plan. Supplier decisions with architecture or validation implications should therefore be synchronized with design decisions.
The handoff from development into manufacturing should be treated as a controlled transition rather than a document delivery event. Both sides need an agreed definition of readiness. Depending on the industry, this may include released specifications, validated processes, approved suppliers, trained operators, tooling acceptance, quality plans, test methods, regulatory status, configuration records, service documentation, and resolution of significant open issues.
Ownership during the transition must also be explicit. Organizations frequently encounter a period during which manufacturing believes engineering still owns the product while engineering believes responsibility has transferred. The development model should identify when operational ownership changes and which issues remain the responsibility of R&D after transfer. A defined stabilization period can be useful for complex launches.
Handoffs should include exception management. A program may reach transfer with known issues that do not justify delaying launch. Those issues should be visible, risk assessed, assigned to owners, and formally accepted by the appropriate authority. Informal acceptance of unresolved problems leads to disputes when they later affect yield, quality, cost, or customer performance.
Metrics should discourage local optimization. Engineering should not be rewarded solely for reaching design freeze if downstream teams experience extensive rework. Manufacturing should not reject reasonable development variation simply to protect plant efficiency. Shared measures such as successful transfer, first-pass yield, post-release engineering changes, or time to stable production can reinforce end-to-end accountability.
When manufacturing or other downstream capabilities reside in another company, the interface requires even greater specificity. Joint ventures may develop a product that a parent company manufactures under a service arrangement. The parties should define input requirements, capacity commitments, change-control rights, acceptance authority, cost responsibilities, and escalation routes. Legal agreements may establish obligations, but operating procedures are still required to manage everyday technical interaction.
The central principle is that these functions should not be treated as final checkpoints. They are design partners with distinct accountabilities. The development model should involve them early enough to prevent predictable problems while preserving clear authority for program leadership and technical execution.
6.4 Clarifying Interfaces with Product Management, Marketing, and Commercial Teams
The upstream and market-facing side of development presents a different interface challenge. Product management, marketing, sales, and commercial leaders bring information about customer needs, pricing, competitive positioning, market timing, channel requirements, and economic value. R&D translates parts of that information into technical requirements and development choices. Problems arise when commercial aspirations remain unstable or implicit while technical commitments become increasingly difficult to change.
The development model should begin by distinguishing customer needs from technical solutions. Product management or an equivalent business role typically involves the articulation of market problems, target customers, desired outcomes, competitive positioning, and product economics. R&D owns the technical system required to address those needs. Both sides participate in translating customer requirements into specifications, but neither should silently assume the other’s accountability.
Requirement ownership is particularly important. A product manager may request a performance feature without understanding its engineering consequences, while an engineering team may simplify a requirement in ways that change customer value. Material changes should therefore follow an explicit decision process that considers commercial benefit, technical feasibility, cost, schedule, and downstream impact.
Requirements should also have a hierarchy. Market needs describe what customers or users require. Product requirements translate those needs into measurable outcomes. Technical specifications define how the system will perform. Mixing these levels creates confusion. Teams may debate a technical solution when the underlying customer priority has never been resolved.
Marketing and commercial involvement should increase at appropriate points in development. Early participation helps test the value proposition and competitive context. Later participation supports pricing, channel readiness, demand planning, sales enablement, and launch sequencing. The development model should identify the information R&D needs from these teams and when decisions become sufficiently committed that late changes require formal trade-offs.
Commercial pressure often increases as launch approaches. Sales teams may request customer-specific modifications, marketing may alter claims, or competitors may introduce features that change perceived requirements. The operating model should provide a disciplined mechanism for evaluating such changes rather than allowing development teams to accept them informally. Each material change should make schedule, resource, technical, regulatory, and manufacturing consequences visible.
Product management should also play an active role in portfolio termination. Commercial sponsors can become advocates for programs they helped create, even after evidence weakens. Portfolio governance should therefore separate objective market evidence from sponsorship. The product leader’s recommendation is important, but continuation decisions should consider the opportunity cost of resources across the portfolio.
Launch readiness is a cross-functional outcome. Technical completion without pricing, demand planning, channel preparation, training, customer support, or communications can destroy value. Conversely, commercial organizations should not commit externally to dates or specifications that the development process has not credibly validated. A shared launch-readiness mechanism should synchronize these activities.
Interfaces vary substantially by business model. In software, product management and engineering may operate together continuously in durable product teams rather than through formal handoffs. In industrial equipment, sales input may enter through configured requirements for individual customers. In consumer products, brand and marketing teams may have significant authority over concept and positioning while R&D owns formulation, packaging, and manufacturability. The model should reflect the nature of the work rather than impose a single functional sequence.
Joint ventures add questions about which organization owns the customer interface. A venture may perform development while one or both parent companies control marketing and distribution. In that case, product requirements, market intelligence, launch timing, and commercial commitments cross organizational boundaries. Governance should specify whose market assumptions are authoritative, how conflicting parent priorities are resolved, and how commercial changes are communicated into development.
The objective of the interface is not to eliminate tension between commercial ambition and technical reality. That tension is productive when managed explicitly. The development model should ensure that customer value shapes technical work while requiring commercial decisions to recognize the economic and operational consequences of change.
6.5 Defining Milestone Ownership, Entry/Exit Criteria, and Handoff Checklists
Development processes become executable when milestones have accountable owners and objective readiness criteria. Without these mechanisms, programs can appear to progress while unresolved work moves downstream. Teams may declare a phase complete because scheduled activities occurred rather than because the evidence needed for the next phase is actually available.
Each major milestone should have one accountable owner. That person is responsible for integrating the necessary work and presenting a coherent recommendation concerning readiness. Contributors may come from many functions, and certain functions may retain independent approval authority, but one role should be accountable for ensuring that the milestone is addressed as an end-to-end outcome.
Milestone ownership should not be confused with ownership of every deliverable. A program leader may own overall readiness while engineering owns technical evidence, quality owns assurance activities, manufacturing owns process readiness, and commercial teams own launch preparation. The milestone owner integrates those contributions and surfaces unresolved dependencies.
Entry criteria define what must be true before significant work begins in a phase. These criteria prevent teams from starting activities that cannot proceed productively. For example, detailed development may require an approved product concept, sufficiently stable requirements, available architecture, an agreed regulatory pathway, and committed resources. Beginning without these inputs often creates apparent schedule progress followed by expensive rework.
Exit criteria define the evidence required to declare a phase complete. Good criteria are outcome based rather than activity based. “Testing completed” is weak because it says nothing about the result. “Critical performance requirements demonstrated within approved limits and unresolved failures dispositioned” is more useful. Criteria should tell the next owner whether the work is mature enough to accept.
Not every criterion needs to be completely satisfied for progression. Complex programs often carry residual risks forward. The model should distinguish mandatory criteria from criteria that can be waived under defined authority. Any waiver should identify the residual risk, responsible owner, closure plan, and decision maker accepting the exposure.
Handoff checklists translate readiness criteria into a practical tool. Their purpose is not to reproduce every process requirement but to prevent recurring omissions at important transitions. A research-to-development checklist might address reproducibility, intellectual property, technical assumptions, known failure modes, prototype evidence, documentation, and availability of researchers for transition support. A design-transfer checklist might cover specifications, validation evidence, tooling, suppliers, quality documentation, configuration, training, open issues, and ownership after transfer.
A strong checklist is specific to the handoff and short enough to be used. Excessively long checklists encourage teams to treat completion as an administrative exercise. Items should be included because their absence has a meaningful chance of causing delay, rework, compliance failure, or misunderstanding downstream.
A practical milestone template can include:
- Milestone purpose: the commitment or transition the milestone enables.
- Accountable owner: the person responsible for integrated readiness.
- Entry criteria: conditions required before the phase begins.
- Exit evidence: outcomes that must be demonstrated before progression.
- Functional approvals: any independent quality, regulatory, technical, manufacturing, or financial authorities required.
- Open risks: unresolved issues permitted to move forward and the conditions attached to them.
- Next owner: the role accepting responsibility after the handoff.
Readiness should be reviewed before the formal decision, not discovered during the gate meeting. Program teams should know which evidence is missing and whether any exception requires escalation. This allows the governance forum to focus on judgment and trade-offs rather than basic completeness checking.
Organizations should also track handoff quality after the fact. Useful measures include downstream rework attributable to incomplete transfer, milestone reversals, post-release engineering changes, late requirement changes, time spent waiting for missing information, and issues repeatedly carried across gates. These indicators show whether criteria are improving flow or merely creating paperwork.
For joint ventures and partnerships, handoff acceptance should identify the organizational entity as well as the role. If one parent transfers technology into a venture or the venture transfers a product to a parent-operated manufacturing site, both parties need a shared definition of completion. Acceptance authority, documentation, unresolved liabilities, confidentiality requirements, and ongoing technical-support obligations should be explicit.
Milestones, criteria, and checklists are therefore operating controls rather than administrative artifacts. Used well, they create disciplined transitions without requiring constant management intervention. They tell teams what sufficient readiness means, identify who owns the result, and prevent incomplete work from quietly becoming someone else’s problem.
